Clear Harbor Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.3K	Sell	44,130 -14,580	-25%	-$26.1K	﹤0.01%	438
2025 Q4	$110K	Sell	58,710 -66,584	-53%	-$128K	0.01%	426
2025 Q3	$160K	Buy	125,294 +2,400	+2%	+$3.25K	0.01%	400
2025 Q2	$152K	Sell	122,894 -290	-0.2%	-$335	0.01%	391
2025 Q1	$145K	Buy	123,184 +9,298	+8%	+$14.3K	0.01%	382
2024 Q4	$208K	Sell	113,886 -6,000	-5%	-$11.7K	0.02%	349
2024 Q3	$204K	Sell	119,886 -50	-0%	-$82	0.02%	336
2024 Q2	$164K	Buy	119,936 +5,000	+4%	+$10.1K	0.01%	337
2024 Q1	$431K	Buy	114,936 +50,886	+79%	+$298K	0.04%	240
2023 Q4	$628K	Buy	64,050 +7,400	+13%	+$60.5K	0.06%	194
2023 Q3	$473K	Sell	56,650 -600	-1%	-$6.86K	0.05%	212
2023 Q2	$761K	Buy	57,250 +36	+0.1%	+$438	0.07%	171
2023 Q1	$663K	Buy	57,214 +3,662	+7%	+$36.4K	0.07%	199
2022 Q4	$438K	Buy	53,552 +3,802	+8%	+$32.8K	0.05%	224
2022 Q3	$289K	Hold	49,750	–	–	0.04%	265
2022 Q2	$220K	Buy	+49,750	New	+$302K	0.03%	314
2020 Q4	–	Sell	-5,500	Closed	-$54.3K	–	610
2020 Q3	$54.3K	Buy	+5,500	New	+$31.7K	0.01%	384